Using AI to spot lung scarring on CT scans
Part of Lungs & breathing clinical trials.
This study tests whether an AI tool can correctly find lung scarring (pulmonary fibrosis) on CT scans as well as doctors do. The results could lead to faster, more consistent detection of this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 20 or older
- Had a chest CT scan at Taichung Veterans General Hospital between 2020 and 2024
- Your CT images and radiology report are available for review
- No heart implants, severe pneumonia, or other issues that would make the scan hard to read
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if a computer program can reliably measure the amount of lung scarring on chest CT scans. It's for people with certain types of interstitial lung disease who are already scheduled for a routine CT scan.
This study uses a single lung scan to find early signs of progressive scarring (fibrosis) in people with pulmonary fibrosis. It may help doctors predict which patients will get worse faster.
This early (Phase 1) study compares two types of PET-CT scans to see how well they detect and measure lung scarring (pulmonary fibrosis). It may help doctors choose the best scan test for diagnosis in the future.
This study is testing a new way to track lung scarring (fibrosis) over time in people with conditions like IPF, other fibrotic lung diseases, or early signs of scarring. It might help doctors understand how the disease changes.
This trial uses artificial intelligence to improve low-dose CT scans for early lung cancer detection. If you are at higher risk due to smoking or family history, or just want a routine check, you may be able to join.
This trial tests an artificial intelligence tool that helps doctors identify lung changes caused by viral pneumonia, like COVID-19, on CT scans. It may lead to faster and more accurate diagnosis for patients.
Hear when a new Pulmonary Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.